$1.390
+0.320 (+23.01%)收盘时
- 最高
- 1.450
- 开盘
- 1.320
- 成交量加权均价
- 1.30
- 成交量
- 11.88M
- 市值
- —
- 最低
- 1.070
- 成交额
- 15.48M
- 企业价值/息税折旧摊销前利润（TTM）
- 0.00
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market.
AI 分析 of PomDoctor Ltd (POM)
持有PomDoctor Ltd is currently not a strong buy due to significant financial challenges, despite a recent price surge. The stock closed at 1.17, down 42.36% yesterday, and has a negative forward P/E ratio, indicating ongoing losses. The recent 5-day change of +85.21% suggests volatility, but the year-to-date change of -80.06% raises concerns about long-term stability. The main risk is the company's current ratio of 0.35, indicating potential liquidity issues.
估值指标
事件时间线
资讯
8.510-19PRnewswirePomdoctor Terminates ADR Program, Lists on Nasdaq
- 8.510-12PRnewswire
Pomdoctor Advances Predictive Healthcare Transformation
- 8.510-09PRnewswire
Pomdoctor Faces Nasdaq Delisting Risk Due to Low Share Price
- 7.509-30PRnewswire
Pomdoctor Advances AI Chronic Disease Management System
7.509-30NewsfilterPomdoctor Advances AI Chronic Disease Management System
POM 常见问题 —— 由 Alphio AI 解答
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector.
PomDoctor Ltd is currently not a strong buy due to significant financial challenges, despite a recent price surge. The stock closed at 1.17, down 42.36% yesterday, and has a negative forward P/E ratio, indicating ongoing losses. The recent 5-day change of +85.21% suggests volatility, but the year-to-date change of -80.06% raises concerns about long-term stability. The main risk is the company's current ratio of 0.35, indicating potential liquidity issues.
社区
更多 ↗暂无帖子
注册或登录后参与讨论本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。